123 related articles for article (PubMed ID: 10566613)
1. Strategies to eradicate minimal residual disease in small cell lung cancer: high-dose chemotherapy with autologous bone marrow transplantation, matrix metalloproteinase inhibitors, and BEC2 plus BCG vaccination.
Krug LM; Grant SC; Miller VA; Ng KK; Kris MG
Semin Oncol; 1999 Oct; 26(5 Suppl 15):55-61. PubMed ID: 10566613
[TBL] [Abstract][Full Text] [Related]
2. Targeting lethal minimal residual disease in small cell lung cancer.
Patel JD; Krug LM; Azzoli CG; Gomez J; Kris MG; Miller VA
Semin Oncol; 2003 Feb; 30(1):79-85. PubMed ID: 12635092
[TBL] [Abstract][Full Text] [Related]
3. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
Grant SC; Kris MG; Houghton AN; Chapman PB
Clin Cancer Res; 1999 Jun; 5(6):1319-23. PubMed ID: 10389914
[TBL] [Abstract][Full Text] [Related]
4. Alternatives to chemotherapy and radiotherapy in the treatment of small cell lung cancer.
Shepherd FA
Semin Oncol; 2001 Apr; 28(2 Suppl 4):30-7. PubMed ID: 11479895
[TBL] [Abstract][Full Text] [Related]
5. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.
Elias AD; Skarin AT; Richardson P; Ibrahim J; McCauley M; Frei E
Biol Blood Marrow Transplant; 2002; 8(6):326-33. PubMed ID: 12108918
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation for the treatment of lung cancer.
Lazarus HM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):72-9. PubMed ID: 8211219
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in management of small-cell lung cancer.
Chua YJ; Steer C; Yip D
Cancer Treat Rev; 2004 Oct; 30(6):521-43. PubMed ID: 15325033
[TBL] [Abstract][Full Text] [Related]
8. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
Giaccone G; Debruyne C; Felip E; Chapman PB; Grant SC; Millward M; Thiberville L; D'addario G; Coens C; Rome LS; Zatloukal P; Masso O; Legrand C
J Clin Oncol; 2005 Oct; 23(28):6854-64. PubMed ID: 16192577
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and biological aspects of intensive chemotherapy with autologous bone marrow grafts in small-cell bronchial cancer].
Symann M; Humblet Y; Bosly A
Bull Mem Acad R Med Belg; 1989; 144(3-4):213-21; discussion 222-3. PubMed ID: 2553180
[TBL] [Abstract][Full Text] [Related]
10. Small cell lung cancer: have we made any progress over the last 25 years?
Lally BE; Urbanic JJ; Blackstock AW; Miller AA; Perry MC
Oncologist; 2007 Sep; 12(9):1096-104. PubMed ID: 17914079
[TBL] [Abstract][Full Text] [Related]
11. Limited-stage small-cell lung cancer: the current status of combined-modality therapy.
Socinski MA; Bogart JA
J Clin Oncol; 2007 Sep; 25(26):4137-45. PubMed ID: 17827464
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy in small-cell lung cancer.
Pasini F; Durante E; De Manzoni D; Rosti G; Pelosi G
Anticancer Res; 2002; 22(6B):3465-72. PubMed ID: 12552940
[TBL] [Abstract][Full Text] [Related]
13. [Small cell lung cancer (CPC). Management of patients presenting with limited stage small cell carcinoma of the lung].
Le Péchoux C; Besse B; Ferreira I; Bretel JJ; Bruna A; Mazeron R; Amarouch A; Roberti E
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S188-16S197. PubMed ID: 17268357
[TBL] [Abstract][Full Text] [Related]
14. Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer.
Ziske C; Gorschlüter M; Mey U; Offergeld R; Glasmacher A; Schmidt-Wolf IG
Anticancer Res; 2002; 22(6B):3723-6. PubMed ID: 12552983
[TBL] [Abstract][Full Text] [Related]
15. [Possible role of autotransplantation in small cel bronchial carcinoma].
Tiefengraber E; Sebesta C; Kier P; Ruckser R; Habertheuer KH; Hinterberger W
Wien Med Wochenschr; 1995; 145(2-3):50-2. PubMed ID: 7762253
[TBL] [Abstract][Full Text] [Related]
16. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
[TBL] [Abstract][Full Text] [Related]
17. [Small-cell lung cancer].
Pérez-Gracia JL; López-Picazo JM; Martín-Algarra S; Viteri S; García-Foncillas J; Gúrpide A
Rev Med Univ Navarra; 2007; 51(2):7-13. PubMed ID: 17886708
[TBL] [Abstract][Full Text] [Related]
18. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
[TBL] [Abstract][Full Text] [Related]
19. Treatment intensification which includes high-dose induction improves survival of lung carcinoma patients treated by high-dose chemotherapy with hematopoietic progenitor cell rescue but does not prevent high rate of relapses.
Tomeczko J; Pacuszko T; Napora P; Lange A
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S44-7. PubMed ID: 8899171
[No Abstract] [Full Text] [Related]
20. High dose chemotherapy and stem cell support in the treatment of germ cell cancer.
Margolin K
J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
